KNOTNERUS TIM JASPER (Chief Executive Officer) purchased 101.6% of their position (11K shares) of AGOMAB THERAPEUTICS NV on the open market
Open‑market purchase worth $94.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/7/2026ACC: 0002120886-26-000001
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+11K
Net shares
Net buyer
$94.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
11K acquired
Non-Derivative Transactions2
Common shares
Direct
Shares
+6K
Price / share
$8.48
Trade value
$50.88K
% of position
55.4%
10/5/2026
10.82K→16.82K
Common shares
Direct
Shares
+5K
Price / share
$8.70
Trade value
$43.50K
% of position
29.7%
10/6/2026
16.82K→21.82K
Total
Net shares
+11K
Net value
$94.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common shares Direct | 10/5/2026 | P · Purchase | +6K | $8.48 | $50.88K | 55.4% | 10.82K | 16.82K |
| Common shares Direct | 10/6/2026 | P · Purchase | +5K | $8.70 | $43.50K | 29.7% | 16.82K | 21.82K |
| Total | +11K | $94.38K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common shares
IndirectShares owned34.39K
Total
34.39K indirect34.39K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common shares | 34.39K | Indirect |
| Total | 34.39K | 34.39K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported